Have you been paying attention to shares of Merit Medical (MMSI) ? Shares have been on the move with the stock up 8.8% over the past month. The stock hit a new 52-week high of $102.88 in the previous session. Merit Medical has gained 34.2% since the start of the year compared to the 4% move for the Zacks Medical sector and the 4.3% return for the Zacks Medical - Dental Supplies industry.What's Driving the Outperformance?The stock has a great record of positive earnings surprises, as it hasn't missed our ear ...

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to find a great growth stock.By their very nature, these stocks carry above-average risk and volatility. Moreover, if a company's growth story is over or nearing its end, betting on it could lead to significant loss.However, the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the tr ...

SOUTH JORDAN, Utah, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today reported that it has completed the acquisition of Cook Medical’s lead management portfolio. The purchase consideration consisted of a cash payment of approximately $210 million and the assumption of certain liabilities. Merit funded the acquisition payment through a combination of cash on hand and borrowings under its long-term credit facility. “We are pleased to ...

Merit Medical Systems, Inc. (MMSI) reported third-quarter 2024 adjusted earnings per share (EPS) of 86 cents, up 21.1% from the year-ago quarter. The bottom line surpassed the Zacks Consensus Estimate by 7.5%.GAAP EPS for the quarter was 48 cents, up 9.1% year over year.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.MMSI’s Revenue DetailsRevenues grossed $339.8 million in the reported quarter, up 7.8% year over year. The metric topped the Zacks Consensus Estimate by 1.4%.Total revenu ...

Merit Medical Systems, Inc. (NASDAQ:MMSI) Q3 2024 Earnings Conference Call October 30, 2024 5:00 PM ET Company Participants Fred Lampropoulos - Founder, Chairman & Chief Executive Officer Brian Lloyd - Chief Legal Officer & Corporate Secretary Joe Wright - President Raul Parra - Chief Financial Officer Conference Call Participants John Young - Canaccord Jayson Bedford - Raymond James Jason Bednar - Piper Sandler David Rescott - R.W. Baird Mike Matson - Needham Craig Bijou - Bank of America Securities Jim Si ...

Merit Medical (MMSI) reported $339.85 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 7.8%. EPS of $0.86 for the same period compares to $0.75 a year ago. View all Key Company Metrics for Merit Medical here>>> The reported revenue represents a surprise of +1.44% over the Zacks Consensus Estimate of $335.02 million. With the consensus EPS estimate being $0.80, the EPS surprise was +7.50%. While investors closely watch year-over-year changes in headline numbe ...

Third Quarter 2024 Results 1 Merit Medical Investor Call October 30, 2024 Fred Lampropoulos Chairman and CEO Raul Parra CFO m | --- | --- | |----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

Merit Medical (MMSI) came out with quarterly earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.80 per share. This compares to earnings of $0.75 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 7.50%. A quarter ago, it was expected that this maker of disposable medical devices would post earnings of $0.88 per share when it actually produced earnings of $0.92, delivering a surprise of 4.55%. Over the last f ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 0-18592 MERIT MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) Utah 87-0447695 (State or ot ...

Exhibit 99.1 1 | --- | --- | --- | |-------|---------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------| | | | | | | Contacts: | | | | PR/Media Inquiries: Sarah Comstock Merit Medical +1-801-432-2864 sarah.comstock@merit.com | Investor Inquiries: Mike Piccinino, CFA, IRC Westwicke – ICR +1-443-213-0509 mike.piccinino@westwicke.com | FOR IMMEDIATE REL ...